Couverture de GLP-1 Drugs and Sleep Apnea — A Breakthrough?

GLP-1 Drugs and Sleep Apnea — A Breakthrough?

GLP-1 Drugs and Sleep Apnea — A Breakthrough?

De : Inception Point Ai
Écouter gratuitement

À propos de ce contenu audio

 Discover how tirzepatide became the first FDA-approved drug for obstructive sleep apnea, offering hope to millions struggling with CPAP machines. Julia Cartwright investigates the science, patient experiences, and clinical implications of this breakthrough treatment that goes far beyond simple weight loss.

For more content like this, visit QuietPlease.ai

This show includes AI-generated content.Copyright 2025 Inception Point Ai Hygiène et vie saine Maladie et pathologies physiques Science
Épisodes
  • GLP-1 Drugs and Sleep Apnea — Uncover the breakthrough reshaping treatment with Julia Cartwright

    GLP-1 Drugs and Sleep Apnea — Uncover the breakthrough reshaping treatment with Julia Cartwright
    Apr 7 2026
    Join Julia Cartwright as she explores the groundbreaking approval of GLP-1 drugs for sleep apnea treatment, a potential game-changer for thirty million Americans frustrated with traditional CPAP therapy. Discover the real science, patient outcomes, and what this breakthrough means for anyone seeking alternatives that actually work.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI

    This episode includes AI-generated content.
    Afficher plus Afficher moins
    1 min
  • GLP-1 Drugs and Sleep Apnea — A Breakthrough? - 30 Million Americans Tired of Their CPAP

    GLP-1 Drugs and Sleep Apnea — A Breakthrough? - 30 Million Americans Tired of Their CPAP
    Apr 7 2026
    Join host Julia Cartwright as she explores tirzepatide's groundbreaking FDA approval for obstructive sleep apnea in adults with obesity. We discuss clinical trials showing remarkable AHI reductions, why CPAP adherence fails millions, the drug's multi-pathway mechanisms, and what this pharmaceutical option means for personalized sleep medicine treatment.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI

    This episode includes AI-generated content.
    Afficher plus Afficher moins
    25 min
  • GLP-1 Drugs and Sleep Apnea — A Breakthrough? - Why Weight Loss Isn't the Whole Story

    GLP-1 Drugs and Sleep Apnea — A Breakthrough? - Why Weight Loss Isn't the Whole Story
    Apr 7 2026
    Host Julia Cartwright explores groundbreaking research on GLP-1 drugs and sleep apnea, revealing how medications like tirzepatide work beyond weight loss through brain receptors, anti-inflammatory effects, and metabolic improvements. Drawing on SURMOUNT-OSA trials and emerging science, she explains why these multi-pathway treatments are revolutionizing our understanding of obstructive sleep apnea as a whole-body condition.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI

    This episode includes AI-generated content.
    Afficher plus Afficher moins
    25 min
Aucun commentaire pour le moment